BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20427671)

  • 1. Identification of Caspase-6-mediated processing of the valosin containing protein (p97) in Alzheimer's disease: a novel link to dysfunction in ubiquitin proteasome system-mediated protein degradation.
    Halawani D; Tessier S; Anzellotti D; Bennett DA; Latterich M; LeBlanc AC
    J Neurosci; 2010 Apr; 30(17):6132-42. PubMed ID: 20427671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system.
    Meyer H; Bug M; Bremer S
    Nat Cell Biol; 2012 Feb; 14(2):117-23. PubMed ID: 22298039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tissue-specific Rep8/UBXD6 tethers p97 to the endoplasmic reticulum membrane for degradation of misfolded proteins.
    Madsen L; Kriegenburg F; Vala A; Best D; Prag S; Hofmann K; Seeger M; Adams IR; Hartmann-Petersen R
    PLoS One; 2011; 6(9):e25061. PubMed ID: 21949850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved protein with AN1 zinc finger and ubiquitin-like domains modulates Cdc48 (p97) function in the ubiquitin-proteasome pathway.
    Sá-Moura B; Funakoshi M; Tomko RJ; Dohmen RJ; Wu Z; Peng J; Hochstrasser M
    J Biol Chem; 2013 Nov; 288(47):33682-33696. PubMed ID: 24121501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2.
    Chan NC; den Besten W; Sweredoski MJ; Hess S; Deshaies RJ; Chan DC
    J Biol Chem; 2014 Jul; 289(28):19789-98. PubMed ID: 24855649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p97: The cell's molecular purgatory?
    Halawani D; Latterich M
    Mol Cell; 2006 Jun; 22(6):713-717. PubMed ID: 16793541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COP9 signalosome interacts ATP-dependently with p97/valosin-containing protein (VCP) and controls the ubiquitination status of proteins bound to p97/VCP.
    Cayli S; Klug J; Chapiro J; Fröhlich S; Krasteva G; Orel L; Meinhardt A
    J Biol Chem; 2009 Dec; 284(50):34944-53. PubMed ID: 19826004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms targeting apolipoprotein B100 to proteasomal degradation: evidence that degradation is initiated by BiP binding at the N terminus and the formation of a p97 complex at the C terminus.
    Rutledge AC; Qiu W; Zhang R; Kohen-Avramoglu R; Nemat-Gorgani N; Adeli K
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):579-85. PubMed ID: 19164805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valosin-containing Protein (VCP)/p97 Segregase Mediates Proteolytic Processing of Cockayne Syndrome Group B (CSB) in Damaged Chromatin.
    He J; Zhu Q; Wani G; Sharma N; Wani AA
    J Biol Chem; 2016 Apr; 291(14):7396-408. PubMed ID: 26826127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways.
    Chou TF; Brown SJ; Minond D; Nordin BE; Li K; Jones AC; Chase P; Porubsky PR; Stoltz BM; Schoenen FJ; Patricelli MP; Hodder P; Rosen H; Deshaies RJ
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4834-9. PubMed ID: 21383145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities.
    Wang Q; Song C; Li CC
    Biochem Biophys Res Commun; 2003 Jan; 300(2):253-60. PubMed ID: 12504076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal Region of the Ubiquitin Regulatory X (UBX) Domain-containing Protein 1 (UBXD1) Modulates Interdomain Communication within the Valosin-containing Protein p97.
    Trusch F; Matena A; Vuk M; Koerver L; Knævelsrud H; Freemont PS; Meyer H; Bayer P
    J Biol Chem; 2015 Dec; 290(49):29414-27. PubMed ID: 26475856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p97-dependent protein degradation by Eeyarestatin I.
    Wang Q; Li L; Ye Y
    J Biol Chem; 2008 Mar; 283(12):7445-54. PubMed ID: 18199748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment.
    Foveau B; Albrecht S; Bennett DA; Correa JA; LeBlanc AC
    Acta Neuropathol Commun; 2016 Dec; 4(1):127. PubMed ID: 27931265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UBX protein SAKS1 negatively regulates endoplasmic reticulum-associated degradation and p97-dependent degradation.
    LaLonde DP; Bretscher A
    J Biol Chem; 2011 Feb; 286(6):4892-901. PubMed ID: 21135095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The UBX domain in UBXD1 organizes ubiquitin binding at the C-terminus of the VCP/p97 AAA-ATPase.
    Blueggel M; Kroening A; Kracht M; van den Boom J; Dabisch M; Goehring A; Kaschani F; Kaiser M; Bayer P; Meyer H; Beuck C
    Nat Commun; 2023 Jun; 14(1):3258. PubMed ID: 37277335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p97 dysfunction underlies a loss of quality control of damaged membrane proteins and promotes oxidative stress and sickling in sickle cell disease.
    Song A; Wen AQ; Wen YE; Dzieciatkowska M; Kellems RE; Juneja HS; D'Alessandro A; Xia Y
    FASEB J; 2022 May; 36(5):e22246. PubMed ID: 35405035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of p97 AAA ATPase inhibitors.
    Chou TF; Deshaies RJ
    Autophagy; 2011 Sep; 7(9):1091-2. PubMed ID: 21606684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
    Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
    Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p97/VCP at the intersection of the autophagy and the ubiquitin proteasome system.
    Ju JS; Weihl CC
    Autophagy; 2010 Feb; 6(2):283-5. PubMed ID: 20083896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.